VTR - NYSE

Ventas, Inc.

VTR·NYSE

$79.10

-1.3%

Real EstateREIT - Healthcare Facilities

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$38.46B

EPS0.5500

P/E Ratio143.82

Earnings Date07/29/2026

27.59B

Assets

3Y+14.0%

5Y+15.0%

10Y+19.0%

15.01B

Total Liabilities

-2%

3Y+8.0%

5Y+10.0%

10Y+19.0%

12.59B

Total Equity

16%

3Y+23.0%

5Y+22.0%

10Y+20.0%

Ventas, Inc. Funding & Solvency Profile

VTR · NYSE

Current Assets

Cash & Cash Equivalents741.07M

Net Receivables415.57M

Inventory0.00

Other Current Assets88.06M

Total Current Assets1 B

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets1.06B

Long-Term Investments718.18M

Other Non-Current Assets24.49B

Total Non-Current Assets25 B

Total Assets

27.59B

Financial Health Analysis

Current Ratio

0.96x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

1.19x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

-61864000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

5% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Negative working capital with limited cash reserves requires immediate attention—potential liquidity crisis if not addressed promptly.

Ventas, Inc. Balance Sheet

VTR • NYSE

Ventas, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	741.1M	897.9M	508.8M	122.6M	149.7M	413.3M	106.4M	72.3M	81.4M	286.7M	53M	55.3M	94.8M	67.9M	45.8M	21.8M	107.4M	176.8M	28.3M	1.2M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	237.6M	237.4M	206.4M	54.7M	55M	63.7M	63.1M	21.5M	0.0	43.3M	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	741.1M	897.9M	508.8M	122.6M	149.7M	650.9M	343.7M	278.7M	136M	341.8M	116.7M	118.5M	116.3M	67.9M	89.1M	21.8M	107.4M	176.8M	28.3M	1.2M
Net Receivables	415.6M	375.7M	248.2M	748.9M	726M	832.4M	1B	800.1M	1.6B	944.1M	1.1B	945M	505.6M	755.3M	309.5M	0.0	0.0	0.0	2.1M	2.5M
Accounts Receivables	250.8M	202.7M	194.1M	187.5M	176.9M	169.7M	278.8M	250M	267.8M	244.6M	219.1M	187.6M	150.8M	120.3M	96.9M	0.0	0.0	0.0	0.0	0.0
Other Receivables	164.7M	173M	54.1M	561.4M	549.2M	662.6M	768.3M	550M	1.4B	699.5M	831.4M	757.4M	354.8M	635M	212.6M	0.0	0.0	0.0	2.1M	2.5M
Prepaids	81.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	88.1M	78M	111.2M	93.1M	75.3M	47.9M	125.3M	64.6M	172.3M	135.6M	171M	2.6B	240M	217.5M	195.9M	38.9M	39.8M	55.9M	52M	77.6M
Total Current Assets	1.3B	1.4B	868.2M	964.6M	951M	1.5B	1.5B	1.1B	1.9B	1.4B	1.3B	3.7B	861.9M	1B	594.5M	60.8M	147.2M	232.7M	82.4M	81.3M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9B	5.3B	5.1B	5.2B	5.5B	3.1B
Goodwill	1B	1B	1B	1B	1B	1.1B	1.1B	1.1B	1B	1B	1B	472.1M	476.5M	515.4M	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	10.7M	11.5M	5.6M	6.4M	7.3M	4.7M	5.1M	5.6M	6.5M	8.2M	13.2M	19.1M	1B	981.7M	800.9M	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1B	1B	1.1B	383.1M	1.5B	1.5B	462.7M	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	718.2M	721.7M	678.5M	675.3M	597.1M	507.5M	104.3M	105.2M	173.4M	124.4M	123.9M	167.9M	91.7M	95.4M	105.3M	15.3M	0.0	0.0	5.5B	3B
Tax Assets	2.8M	1.9M	1.8M	10.5M	11.2M	10M	47.5M	205.2M	250.1M	316.6M	-18.9B	344.3M	250.2M	259.7M	0.0	241.3M	253.7M	257.5M	297.6M	30.4M
Other Non-Current Assets	24.5B	23.1B	22.1B	21.5B	22.1B	20.8B	22B	20.3B	20.8B	20.6B	19.7B	16.9B	18.3B	17.3B	195.7M	402.4M	339.9M	365.8M	-5.3B	-3B
Total Non-Current Assets	26.3B	24.8B	23.9B	23.2B	23.8B	22.4B	23.2B	21.4B	22B	21.7B	20.9B	17.5B	18.9B	17.9B	16.7B	5.7B	5.5B	5.5B	5.6B	3.2B
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3B
Total Assets	27.6B	26.2B	24.7B	24.2B	24.7B	23.9B	24.7B	22.6B	24B	23.2B	22.3B	21.2B	19.7B	19B	17.3B	5.8B	5.6B	5.8B	5.7B	3.3B
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.2B	1.2B	1B	1B	1.1B	1.1B	1.1B	1.1B	1.2B	907.9M	779.4M	750.7M	1B	995.2M	1.1B	207.1M	190.4M	168.2M	173.6M	156M
Accounts Payable	1.2B	1.2B	1B	1B	1.1B	1.1B	1.1B	1.1B	1.2B	907.9M	779.4M	750.7M	1B	995.2M	1.1B	207.1M	190.4M	168.2M	173.6M	114M
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-114M
Accrued Expenses	143.1M	143.3M	117.4M	110.5M	106.6M	111.4M	111.1M	99.7M	94M	83.8M	80.9M	62.2M	54.3M	47.6M	37.7M	19.3M	18M	21.9M	20.8M	19.9M
Short Term Debt	0.0	6.4M	14M	428.2M	336.4M	193.5M	848.7M	856.4M	538.7M	146.5M	180.7M	919.1M	376.3M	540.7M	455.6M	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3M	7.1M	9.1M	8.2M
Other Current Liabilities	4M	2.7M	9.2M	6.5M	10.9M	3.2M	5.2M	205K	60.3M	1.5M	34.3M	238M	0.0	0.0	0.0	241.3M	249.4M	0.0	0.0	0.0
Total Current Liabilities	1.4B	1.3B	1.2B	1.6B	1.5B	1.4B	2.1B	2B	1.9B	1.1B	1.1B	2B	1.4B	1.6B	1.6B	467.8M	462.1M	197.2M	203.4M	184.1M
NON-CURRENT LIABILITIES
Long Term Debt	13B	13.5B	13.5B	11.9B	11.7B	11.7B	11.3B	9.9B	10.7B	11B	11B	9.9B	9B	7.7B	5.8B	2.9B	2.7B	3.1B	3.4B	2.3B
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2M
Deferred Tax Liabilities (Non-Current)	23.4M	8.2M	24.5M	35.6M	59.3M	62.6M	200.8M	205.2M	250.1M	316.6M	338.4M	344.3M	250.2M	259.7M	0.0	0.0	253.7M	257.5M	297.6M	30.4M
Other Non-Current Liabilities	375.2M	310.2M	302.6M	264.7M	280.3M	235.5M	273.7M	188.1M	158.5M	200.7M	196.5M	172M	156.7M	174.6M	102.8M	0.0	-253.7M	0.0	0.0	-8.2M
Total Non-Current Liabilities	13.6B	14.1B	14B	12.4B	12.2B	12.2B	12B	10.3B	11.1B	11.5B	11.6B	10.4B	9.4B	8.3B	6.3B	2.9B	2.7B	3.4B	3.7B	2.4B
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-76K
Capital Lease Obligations	208.6M	218M	194.7M	190.4M	197.2M	209.9M	251.2M	0.0	0.0	0.0	0.0	0.0	0.0	142.4M	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	15B	15.4B	15.2B	13.9B	13.8B	13.7B	14.1B	12.3B	13B	12.6B	12.6B	12.4B	10.8B	9.9B	7.9B	3.4B	3.1B	3.6B	3.9B	2.5B
SHAREHOLDERS' EQUITY
Treasury Stock	-34K	-25.2M	-13.8M	-536K	0.0	0.0	-132K	0.0	-42K	-47K	-2.6M	-511K	-221.9M	-221.2M	-747K	-748K	-647K	-457K	-626K	0.0
Common Stock	118.7M	109.1M	100.6M	99.9M	99.8M	93.6M	93.2M	89.1M	89M	88.5M	83.6M	74.7M	74.5M	73.9M	72.2M	39.4M	39.2M	35.8M	33.4M	26.5M
Additional Paid-In Capital	20B	17.6B	15.7B	15.5B	15.5B	14.2B	14.1B	13.1B	13.1B	12.9B	11.6B	10.1B	10.1B	9.9B	9.6B	2.6B	2.6B	2.3B	1.8B	766.5M
Retained Earnings	0.0	0.0	0.0	-5.4B	-4.7B	-4B	-3.7B	-2.9B	-2.2B	-2.5B	-2.1B	-1.5B	-1.1B	-777.9M	-412.2M	-255.6M	-165.7M	-117.8M	-47.8M	-84.2M
Accumulated Other Comprehensive Income/Loss	-7.6B	-6.9B	-6.2B	-5.5B	-4.7B	-4.1B	-3.7B	-2.9B	-2.3B	-2.5B	-2.1B	-1.5B	-1.1B	-754.6M	-390.1M	26.9M	19.7M	-21.1M	17.4M	1M
Other Total Stockholders' Equity	0.0	0.0	0.0	5.4B	4.7B	4B	3.7B	2.9B	2.2B	2.5B	2.1B	1.5B	1.1B	777.9M	412.2M	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	12.5B	10.8B	9.5B	10.2B	10.9B	10.2B	10.4B	10.2B	10.9B	10.5B	9.6B	8.7B	8.8B	9B	9.3B	2.4B	2.5B	2.1B	1.8B	709.9M
Total Equity	12.6B	10.8B	9.5B	10.2B	10.9B	10.3B	10.5B	10.3B	10.9B	10.5B	9.6B	8.8B	8.9B	9.1B	9.4B	2.4B	2.5B	2.2B	1.9B	710.3M
Minority Interest	58.6M	58.3M	56.3M	68.7M	91.4M	98M	99.6M	55.7M	66M	68.5M	61.1M	74.2M	79.5M	70.2M	81M	3.5M	18.5M	19.1M	31.5M	393K
SUMMARY
Total Liabilities & Equity	27.6B	26.2B	24.7B	24.2B	24.7B	23.9B	24.7B	22.6B	24B	23.2B	22.3B	21.2B	19.7B	19B	17.3B	5.8B	5.6B	5.8B	5.7B	3.3B
Total Investments	718.2M	721.7M	678.5M	675.3M	597.1M	745M	341.7M	311.6M	228M	179.4M	187.6M	231M	113.1M	95.4M	148.6M	15.3M	0.0	0.0	5.5B	3B
Total Debt	13.2B	13.7B	13.7B	12.5B	12.2B	12.1B	12.4B	10.7B	11.3B	11.1B	11.2B	10.8B	9.4B	8.4B	6.4B	2.9B	2.7B	3.1B	3.4B	2.3B
Net Debt	12.5B	12.8B	13.2B	12.4B	12.1B	11.7B	12.3B	10.7B	11.2B	10.8B	11.2B	10.8B	9.3B	8.3B	6.4B	2.9B	2.6B	3B	3.3B	2.3B
Shares Outstanding	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468	442,426,468

SEC Filings

VTR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 15, 2026	May 12, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 28, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 27, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 01, 2026	May 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 20, 2026	February 16, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 09, 2026	February 09, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 06, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 05, 2026	February 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 07, 2026	January 07, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 04, 2025	December 02, 2025	2025	View Filing

Showing 1 to 10 of 672 filings

Related Guides

Blog Categories

Continue your VTR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.